Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Director
On May 11, 2022, Jean-Pierre Sommadossi, Ph.D., Chairman of the Board of
Directors (the "Board") of Kezar Life Sciences, Inc. (the "Company") tendered
his resignation from the Board effective immediately. In connection with his
resignation from the Board, Dr. Sommadossi also resigned from all committees of
the Board on which he served, including the Compensation Committee. The decision
by Dr. Sommadossi to resign was not the result of any disagreements with the
Board or management of the Company.
Appointment of Chairman
Following Dr. Sommadossi's resignation, on May 12, 2022, the Board appointed
current director Graham Cooper as Chairman of the Board, and in connection with
the appointment, the Board granted Mr. Cooper a one-time option to purchase
26,000 shares of the Company's common stock (the "Option"). Subject to Mr.
Cooper's continued service on the Board, the Option will vest in equal monthly
amounts over three years.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses